Presentations & Talks

• EURO EWING Consortium 22nd Network Meeting, London (UK), 1/7/2025.
  “Emulating a target trial to evaluate dose modifications and delays in VDC/IE therapy: Insights from Euro-Ewing 2012"

• General Mathematics Colloquium @Leiden University, Leiden (NL), 8/5/2025.
  “Causal effects of chemotherapy regimen dose intensity on survival outcome: a retrospective study in osteosarcoma"

• EURO EWING Consortium 20th Network Meeting, London (UK), 25/6/2024.

"INDICATES: INDIvidualized loCAl Therapy for Ewing Sarcoma"

• Causal Inference & AI for Health Meeting @LDE [Leiden University, TU Delft, Erasmus MC Rotterdam], Leiden (NL), 23/10/2023.
  "Investigating positivity violations in marginal structural survival models: a study on estimator IPTW performance" 

• Department of Economics, Business and Statistics, University of Palermo, Palermo (IT), 16/3/2023.
  “Causal effects of chemotherapy regimen intensity on survival outcome in osteosarcoma patients through Marginal Structural Cox Models"

• Health Data Science Special Interest Group @Leiden University, Leiden (NL), 26/1/2023.
  “Causal effects of chemotherapy regimen intensity on survival outcome in osteosarcoma patients through Marginal Structural Cox Models"

• Princess Máxima Center for Pediatric Oncology, Utrecht (NL), 24/1/2023.
  “Causal effects of chemotherapy regimen intensity on survival outcome in osteosarcoma patients through Marginal Structural Cox Models"

• PhD Colloquium @Mathematical Institute, Leiden University, Leiden (NL), 7/6/2022.
  “My PhD journey & my research"

• Health Data Science Special Interest Group @Leiden University, Leiden (NL), 16/12/2021.
  “Modelling longitudinal Latent Overall Toxicity (LOTox) profiles in osteosarcoma patients”

• European Organisation for Research and Treatment of Cancer, Bruxelles (Belgium), 30/11/2021.
  “Modelling longitudinal Latent Overall Toxicity (LOTox) profiles in osteosarcoma patients”

• Statistics Group @Leiden University Medical Center, Leiden (NL), 25/11/2021.
  “Modelling longitudinal Latent Overall Toxicity (LOTox) profiles in osteosarcoma patients”

• Survival Group @Leiden University Medical Center, Leiden (NL), 26/4/2021.
  “Modelling longitudinal latent toxicity profiles evolution in osteosarcoma patients”

• Statistics Group @Mathematical Institute, Leiden University, Leiden (NL), 1/3/2021.
  “Modelling longitudinal latent toxicity profiles in osteosarcoma patients”

• Statistics Group @MOX Laboratory, Politecnico di Milano, Milan (IT), 10/6/2020.
  “Including time-varying covariates in time-to-event framework with applications to heart failure and osteosarcoma”

• QP Group @Leiden Academic Centre for Drug Research, Leiden (NL), 28/5/2020.
  “Including dynamic covariates in survival models via Functional Data Analysis”

• Princess Máxima Center for Pediatric Oncology, Utrecht (NL), 26/5/2020.
  “Including dynamic covariates in survival models via Functional Data Analysis”

• Statistics Group @Mathematical Institute, Leiden University, Leiden (NL), 3/12/2019.
  “Including dynamic covariates in survival models via Functional Data Analysis”

• ISCB45 – 45th Annual Conference of the International Society for Clinical Biostatistics, Thessaloniki (EL), 21-25/7/2024.
  “Cluster-based recurrent marked point process approach for longitudinal volume-outcome studies"

• ISCB43 – 43rd Annual Conference of the International Society for Clinical Biostatistics, Newcastle Upon Tyne (UK), 21-25/8/2022.
  “Causal effects of chemotherapy dose intensity on survival outcome through Marginal Structural Models"

• ISCB40 – 40th Annual Conference of the International Society for Clinical Biostatistics, Leuven (Belgium), 14-18/7/2019.
  “Investigating the role of Proteinuria in Renal Disease: a real-world clinical case study”

• SIS 2018 – 49th Meeting of the Italian Statistical Society, Palermo (IT), 20-22/6/2018.
  "Investigating the effect of drugs consumption on survival outcome of Heart Failure patients using joint models: a case study based on regional administrative data"